Conventional CABG

PROCEDURE3 trials

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM), Ottawa Heart Institute Research Corporation, National Research Center of Surgery, Russia

Conditions

Arrhythmias, CardiacCardiovascular DiseasesCoronary Artery DiseaseMyocardial IschemiaPostoperative Atrial Fibrillation

Unknown Phase

Coronary Artery Bypass Grafting Strategies for the Anterolateral Territory: a Prospective Randomized Clinical Trial

CompletedNCT01585285

Centre hospitalier de l'Université de Montréal (CHUM)Coronary Artery Disease

Start: 2012-07-31End: 2022-04-30Updated: 2022-11-16

The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial

Active, not recruitingNCT03447938

Ottawa Heart Institute Research CorporationCoronary Artery Disease

Start: 2018-09-01End: 2028-03-01Target: 176Updated: 2026-05-12

Randomized Clinical Trial PULVAB (Prophylactic Pulmonary Veins Ablation)

National Research Center of Surgery, RussiaArrhythmias, Cardiac, Cardiovascular Diseases, Myocardial Ischemia +1

Start: 2016-09-01End: 2022-12-01Target: 280Updated: 2020-02-06

Related Papers

Minimally invasive coronary bypass grafting for treating multivessel coronary disease: A single-center prospective pilot study.

2025-05-04

Anterolateral territory coronary artery bypass grafting strategies: a non-inferiority randomized clinical trial: the AMI-PONT trial

European Journal of Cardio-Thoracic Surgery2023-02-184 citations

Radiofrequency pulmonary vein isolation for the prevention of new-onset atrial fibrillation after coronary artery bypass grafting

Patologiya krovoobrashcheniya i kardiokhirurgiya2020-09-301 citations

Composite versus conventional coronary artery bypass grafting strategy for the anterolateral territory: study protocol for a randomized controlled trial.

2013-08-268 citations